0000950103-17-006934.txt : 20170720 0000950103-17-006934.hdr.sgml : 20170720 20170720201636 ACCESSION NUMBER: 0000950103-17-006934 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170720 FILED AS OF DATE: 20170720 DATE AS OF CHANGE: 20170720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Choulika Andre CENTRAL INDEX KEY: 0001712190 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38161 FILM NUMBER: 17975345 MAIL ADDRESS: STREET 1: 600 COUNTY ROAD D WEST STREET 2: SUITE 8 CITY: NEW BRIGHTON STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Calyxt, Inc. CENTRAL INDEX KEY: 0001705843 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 271967997 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 COUNTY ROAD D WEST STREET 2: SUITE 8 CITY: NEW BRIGHTON STATE: MN ZIP: 55112 BUSINESS PHONE: (651) 683-2807 MAIL ADDRESS: STREET 1: 600 COUNTY ROAD D WEST STREET 2: SUITE 8 CITY: NEW BRIGHTON STATE: MN ZIP: 55112 3 1 dp78489_3-choulika.xml FORM 3 X0206 3 2017-07-20 0 0001705843 Calyxt, Inc. CLXT 0001712190 Choulika Andre 600 COUNTY ROAD D WEST SUITE 8 NEW BRIGHTON MN 55112 1 0 0 0 Restricted Stock Units 156800 D Stock Option (Right to Buy) 3.71 2024-12-03 Common Stock 6125 D Stock Option (Right to Buy) 21.83 2025-09-09 Common Stock 25480 D Stock Option (Right to Buy) 3.59 2026-04-07 Common Stock 245000 D Stock Option (Right to Buy) 13.29 2027-06-14 Common Stock 235200 D The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on June 14, 2017 and vests 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months. The Reporting Person is the Chief Executive Officer of Cellectis S.A. ("Cellectis"), the sole shareholder of Calyxt, Inc. as of the time of this filing, and disclaims all beneficial ownership in Cellectis' interest in Calyxt, Inc., except to the extent of any pecuniary interest therein. The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on December 3, 2014, and vests 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter). The Stock Option was granted on September 9, 2015 and vests 20% on the grant date and 20% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following three years (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter). The Stock Option was granted on April 7, 2016 and vests 20% on the grant date and 10% on the first anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months (or with an additional 25% vesting immediately if Calyxt, Inc. undergoes a change in control, liquidation, dissolution or initial public offering and the remainder vesting quarterly thereafter). The Stock Option was granted on June 14, 2017 and vests 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months. /s/ Joseph B. Saluri 2017-07-20 EX-24 2 dp78489_ex24.htm EXHIBIT 24

Exhibit 24

  

 

POWER OF ATTORNEY

 

Know all by these presents, that the undersigned hereby constitutes and appoints each of Bryan W. J. Corkal and Joseph B. Saluri as the undersigned’s true and lawful attorneys-in-fact to:

 

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or member of the Board of Directors of Calyxt, Inc. (the “Company”), Forms 3, 4 and 5, including any amendments thereto, in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations thereunder (the “Exchange Act”);

 

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto and timely file such form with the United States Securities and Exchange Commission and the applicable stock exchange or similar authority; and

 

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of any of such attorneys-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by any of such attorneys-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as any of such attorneys-in-fact may approve in his discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to act separately and to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that any of such attorneys-in-fact, or the substitute or substitutes of any of such attorneys-in-fact, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 17th day of July, 2017.

 

Signature: /s/ André Choulika 
Name: André Choulika